Volume 7.20 | Jun 5

Immune Regulation News 7.20 June 5, 2015
Immune Regulation News
     In this issue: Publications | Reviews | Science News | Industry News | Policy News | Events | Jobs
Like Us on Facebook  IRN on Twitter
The Transcription Factor TFEB Acts as a Molecular Switch that Regulates Exogenous Antigen-Presentation Pathways
Investigators report that TFEB expression inhibited the presentation of exogenous antigen by major histocompatibility complex (MHC) class I while enhancing presentation via MHC class II. Furthermore, they found that the activation of TFEB was regulated during dendritic cell (DC) maturation and that phagosomal acidification was impaired in DCs in which the gene encoding TFEB was silenced. [Nat Immunol] Abstract
Isolate Immune Cells From Whole Blood Without Lysis or Centrifugation with EasySep™ Direct. Request a Free Sample!
PUBLICATIONS (Ranked by impact factor of the journal)
Leukotriene B4-Neutrophil Elastase Axis Drives Neutrophil Reverse Transendothelial Cell Migration In Vivo
Researchers demonstrated that the lipid chemoattractant leukotriene B4 was efficacious at causing loss of venular junctional adhesion molecule-C and promoting neutrophil reverse transendothelial cell migration in vivo. [Immunity] Full Article | Graphical Abstract

IL-2 Is a Critical Regulator of Group 2 Innate Lymphoid Cell Function during Pulmonary Inflammation
Researchers sought to understand the role of IL-2 in the regulation of group 2 innate lymphoid cells (ILC2) function in the lung. They determined the effect of IL-2 administration on pulmonary ILC2 numbers and function in mice in the steady state and after challenge with IL-33. [J Allergy Clin Immunol] Abstract | Press Release

An IL-27/Lag3 Axis Enhances Foxp3+ Regulatory T Cell–Suppressive Function and Therapeutic Efficacy
Scientists report that interleukin (IL)-27, an IL-12 family cytokine known to have both pro- and anti-inflammatory roles in T cells, plays a pivotal role in enhancing regulatory T cell function to control T cell–induced colitis, a model for inflammatory bowel disease in humans. [Mucosal Immunol] Abstract

Critical Roles of Chemoresistant Effector and Regulatory T Cells in Antitumor Immunity after Lymphodepleting Chemotherapy
Investigators demonstrated that both regulatory T cells (Tregs) and effector CD8+ T cells from lymphopenic recipients play critical roles in the development of antitumor immunity after lymphodepletion. Cyclophosphamide (CPA) treatment depleted lymphocytes more efficiently than other cytotoxic agents; however, the percentage of CD4+CD25+ Foxp3+ Tregs was significantly increased in CPA-treated lymphopenic mice. [J Immunol] Abstract

B Lymphocytes Are Required during the Early Priming of CD4+ T Cells for Clearance of Pneumocystis Infection in Mice
Using adoptive transfer and B cell depletion strategies, researchers determined that optimal priming of CD4+ T cells requires B cells during the first two to three days of infection and that this was independent of the production of Ab. [J Immunol] Abstract

Tumor-Specific Th2 Responses Inhibit Growth of CT26 Colon-Cancer Cells in Mice via Converting Intratumor Regulatory T Cells to Th9 Cells
Scientists investigated the role of cancer specific T helper (Th)2 response in the inhibition of colon cancer (Cca) cell growth. The results showed that with Cca cell extracts as an antigen, the Cca-extract specific Th2 response was induced in the Cca-bearing mice. [Sci Rep] Full Article

Endotoxic Shock-Expanded Murine CD11clowCD45RB+ Regulatory Dendritic Cells Modulate Inflammatory T Cell Responses through Multiple Mechanisms
The authors showed that endotoxic shock promotes the expansion of CD11clowCD45RB+ cells with dendritic morphology and the production of low levels of inflammatory cytokines and costimulatory molecules. The expanded cells induced the generation of regulatory T cells, showed incapability to stimulate T cells, and induced apoptosis of CD4+ T cells in vitro. [Sci Rep] Full Article

FOXP3+ T Cells Recruited to Sites of Sterile Skeletal Muscle Injury Regulate the Fate of Satellite Cells and Guide Effective Tissue Regeneration
Researchers assessed the role of the adaptive immune system in muscle regeneration after acute damage. They showed that T lymphocytes are transiently recruited into the muscle after damage and appear to exert a pro-myogenic effect on muscle repair. [PLoS One] Full Article

Don’t forget to subscribe to Human Immunology News and Immunology of Infectious Disease News!

Request a Sample: 8 minutes to highly purified immune cells with EasySep™.
Metabolic Reprogramming in Macrophages and Dendritic Cells in Innate Immunity
Activation of macrophages and dendritic cells by pro-inflammatory stimuli causes them to undergo a metabolic switch towards glycolysis and away from oxidative phosphorylation, similar to the Warburg effect in tumors. However, it is only recently that the mechanisms responsible for this metabolic reprogramming have been elucidated in more detail. [Cell Res] Full Article

Natural Killer T Cells in Multiple Sclerosis and Its Animal Model, Experimental Autoimmune Encephalomyelitis
A desirable outcome of immunotherapy would be to protect against disease prior to its clinical manifestation or to halt disease after its initiation. One attractive approach to accomplish this goal would be to restore tolerance by targeting immunoregulatory cell networks. [Immunology] Abstract | Full Article

Visit our reviews page to see a complete list of reviews in the immune regulation research field.
AbbVie’s Research in Immunology to Be Featured
AbbVie announced that data from more than 30 abstracts on HUMIRA® (adalimumab), investigational medicines and rheumatologic diseases will be presented. [Press release from AbbVie Inc. discussing research to be presented at the 16th European League against Rheumatism (EULAR) Annual Congress, Rome] Press Release

Momenta Pharmaceuticals Announces Oral and Poster Presentations Relating to Novel Autoimmune Programs
Momenta Pharmaceuticals, Inc. announced that new data from studies of the company’s novel autoimmune programs will be presented. [Press release from Momenta Pharmaceuticals, Inc. discussing research to be presented at the 16th European League against Rheumatism (EULAR) Annual Congress, Rome] Press Release

From our sponsor: Learn how HLA labs save resources with RoboSep™. Watch the webinar.
Celgene and bluebird bio to Develop Anti-BCMA Product Candidates; bluebird bio Regains Rights to CAR T Programs Outside of BCMA
bluebird bio, Inc. announced that its existing global collaboration agreement with Celgene Corporation has been amended and restated to focus on developing product candidates targeting B-cell maturation antigen (BCMA) during a three-year collaboration term. [bluebird bio, Inc.] Press Release

LDC and Qurient Close License Agreement on Novel Anti-Cancer Compound
The Lead Discovery Center GmbH (LDC) and Qurient Co., Ltd. have signed a license deal providing Qurient with exclusive worldwide rights to a series of highly-selective CDK7 inhibitors discovered at the LDC for the treatment of cancer, inflammation and viral infections. [Lead Discovery Center GmbH] Press Release
National Institutes of Health (United States)

Food and Drug Administration (United States)

Center for Biologics Evaluation and Research (United States)

European Medicines Agency (European Union)

Medicines and Healthcare Products Regulatory Agency (United Kingdom)

Therapeutic Goods Administration (Australia)
NEW Immuno-Oncology
September 30-October 1, 2015
Alexandria, United States

Visit our events page to see a complete list of events in the immune regulation community.
NEW Scientific Marketing Specialist – Immunology (STEMCELL Technologies Inc.)

NEW Associate Director/Director – Immunology (Valera)

Scientist – Immunology and Cell Separation (STEMCELL Technologies Inc.)

Research Associate – Cell Separation (STEMCELL Technologies Inc.)

PhD Position – Molecular Immunology (VIB – Ghent University)

Head Stem Cells Immunotherapies Service Lab (NHS Blood and Transplant)

Postdoctoral Fellow – Immune Reconstitution in Hematopoietic Stem Cell Transplantation (Stanford University)

Process Facilitator (Opexa Therapeutics)

Postdoctoral Fellow – Immune Tolerance (Stanford University)

Postdoctoral Fellow – Immunology (Boston Children’s Hospital)

Postdoctoral Fellow – Immunopathogenesis of Multiple Sclerosis (University of Iowa)

Senior Scientist – Immunology (National Institute of Immunology)

Assistant Professor – Immunology (Northwestern University)

Recruit Top Talent: Reach more than 60,000 potential candidates by posting your organization’s career opportunities on the Connexon Creative Job Board at no cost.

Have we missed an important article or publication in Immune Regulation News? Click here to submit!

Comments or suggestions? Submit your feedback here
Learn more about Immune Regulation News: Archives | Events | Contact Us